These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30610067)

  • 1. Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial.
    Burggraaf B; van Breukelen-van der Stoep DF; de Vries MA; Klop B; Liem AH; van de Geijn GM; van der Meulen N; Birnie E; van der Zwan EM; van Zeben J; Castro Cabezas M
    Ann Rheum Dis; 2019 Mar; 78(3):335-341. PubMed ID: 30610067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of subclinical atherosclerosis in subjects with rheumatoid arthritis and the metabolic syndrome.
    Burggraaf B; van Breukelen-van der Stoep DF; de Vries MA; Klop B; van Zeben J; van de Geijn GM; van der Meulen N; Birnie E; Prinzen L; Castro Cabezas M
    Atherosclerosis; 2018 Apr; 271():84-91. PubMed ID: 29482038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Value of Arterial Stiffness and Subclinical Carotid Atherosclerosis for Cardiovascular Disease in Patients with Rheumatoid Arthritis.
    Ikdahl E; Rollefstad S; Wibetoe G; Olsen IC; Berg IJ; Hisdal J; Uhlig T; Haugeberg G; Kvien TK; Provan SA; Semb AG
    J Rheumatol; 2016 Sep; 43(9):1622-30. PubMed ID: 27307523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparison of cardiovascular disease risk prediction scores and evaluation of subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study.
    Muhammed H; Misra DP; Jain N; Ganguly S; Pattanaik SS; Rai MK; Anuja AK; Mohindra N; Kumar S; Agarwal V
    Clin Rheumatol; 2022 Dec; 41(12):3675-3686. PubMed ID: 36006556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uric acid is independent cardiovascular risk factor, as manifested by increased carotid intima-media thickness in rheumatoid arthritis patients.
    Hannawi S; AlSalmi I; Moller I; Naredo E
    Clin Rheumatol; 2017 Aug; 36(8):1897-1902. PubMed ID: 28664292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Puerarin on Carotid Intima-media Thickness in Patients With Active Rheumatoid Arthritis: ARandomized Controlled Trial.
    Yang M; Luo Y; Liu T; Zhong X; Yan J; Huang Q; Tao J; He Q; Guo M; Hu Y
    Clin Ther; 2018 Oct; 40(10):1752-1764.e1. PubMed ID: 30245282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis is not accelerated in rheumatoid arthritis of low activity or remission, regardless of antirheumatic treatment modalities.
    Arida A; Protogerou AD; Konstantonis G; Fragiadaki K; Kitas GD; Sfikakis PP
    Rheumatology (Oxford); 2017 Jun; 56(6):934-939. PubMed ID: 28160488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variables associated with subclinical atherosclerosis among rheumatoid arthritis patients of Gulf Cooperative Council countries.
    Hannawi S; Hannawi H; Alokaily F; Al Salmi I
    Saudi Med J; 2020 Feb; 41(2):128-137. PubMed ID: 32020145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of biologic agents on cardiovascular risk factors and atherosclerosis in rheumatoid arthritis patients: a prospective observational study.
    Papamichail GV; Markatseli TE; Georgiadis AN; Xydis VG; Milionis H; Drosos AA; Voulgari PV
    Heart Vessels; 2022 Dec; 37(12):2128-2136. PubMed ID: 35739432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for increased chylomicron remnants in rheumatoid arthritis.
    Burggraaf B; van Breukelen-van der Stoep DF; van Zeben J; van der Meulen N; van de Geijn GM; Liem A; Valdivielso P; Rioja Villodres J; Ramírez-Bollero J; van der Zwan E; Castro Cabezas M
    Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29231984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Methotrexate on Carotid Intima-media Thickness in Patients with Rheumatoid Arthritis.
    Kim HJ; Kim MJ; Lee CK; Hong YH
    J Korean Med Sci; 2015 Nov; 30(11):1589-96. PubMed ID: 26539002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients.
    Dalbeni A; Giollo A; Bevilacqua M; Cioffi G; Tagetti A; Cattazzo F; Orsolini G; Ognibeni F; Minuz P; Rossini M; Fava C; Viapiana O
    Hypertens Res; 2020 Sep; 43(9):922-928. PubMed ID: 32341443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tofacitinib improves atherosclerosis despite up-regulating serum cholesterol in patients with active rheumatoid arthritis: a cohort study.
    Kume K; Amano K; Yamada S; Kanazawa T; Ohta H; Hatta K; Amano K; Kuwaba N
    Rheumatol Int; 2017 Dec; 37(12):2079-2085. PubMed ID: 29030660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study.
    Guin A; Chatterjee Adhikari M; Chakraborty S; Sinhamahapatra P; Ghosh A
    Semin Arthritis Rheum; 2013 Aug; 43(1):48-54. PubMed ID: 23415602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis -- an inception cohort study.
    Ajeganova S; de Faire U; Jogestrand T; Frostegård J; Hafström I
    J Rheumatol; 2012 Jun; 39(6):1146-54. PubMed ID: 22589258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease in rheumatoid arthritis: Current perspectives on assessing and mitigating risk in clinical practice.
    Giles JT
    Best Pract Res Clin Rheumatol; 2015; 29(4-5):597-613. PubMed ID: 26697769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Extent of Subclinical Atherosclerosis Is Partially Predicted by the Inflammatory Load: A Prospective Study over 5 Years in Patients with Rheumatoid Arthritis and Matched Controls.
    Södergren A; Karp K; Bengtsson C; Möller B; Rantapää-Dahlqvist S; Wållberg-Jonsson S
    J Rheumatol; 2015 Jun; 42(6):935-42. PubMed ID: 25877503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular system changes in rheumatoid arthritis patients with continued low disease activity.
    Biskup M; Biskup W; Majdan M; Targońska-Stępniak B
    Rheumatol Int; 2018 Jul; 38(7):1207-1215. PubMed ID: 29774373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical atherosclerosis among rheumatoid arthritis patients without overt cardiovascular risk factors.
    Sahari NS; Shaharir SS; Ismail MR; Rajalingham S; Mohamed Said MS
    Mod Rheumatol; 2014 Nov; 24(6):920-5. PubMed ID: 24645724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The best cardiovascular risk calculator to predict carotid plaques in rheumatoid arthritis patients.
    Wah-Suarez MI; Galarza-Delgado DA; Azpiri-Lopez JR; Colunga-Pedraza IJ; Cardenas-de la Garza JA; Vera-Pineda R; Arvizu-Rivera RI; Martinez-Moreno A; Ramos-Cazares RE; Abundis-Marquez EE; Guillen-Lozoya AH; Davila-Jimenez JA; Guillen-Gutierrez CY; Elizondo-Riojas G
    Clin Rheumatol; 2018 Sep; 37(9):2373-2380. PubMed ID: 29967925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.